ID24566A - Obat untuk alopesia - Google Patents

Obat untuk alopesia

Info

Publication number
ID24566A
ID24566A IDW20000167A ID20000167A ID24566A ID 24566 A ID24566 A ID 24566A ID W20000167 A IDW20000167 A ID W20000167A ID 20000167 A ID20000167 A ID 20000167A ID 24566 A ID24566 A ID 24566A
Authority
ID
Indonesia
Prior art keywords
alopesia
medicine
seborrhea
alopecia
chem
Prior art date
Application number
IDW20000167A
Other languages
English (en)
Indonesian (id)
Inventor
Koichi Kojima
Takakazu Hamada
Shiroh Yosioka
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of ID24566A publication Critical patent/ID24566A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IDW20000167A 1997-07-29 1998-07-27 Obat untuk alopesia ID24566A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20313697 1997-07-29

Publications (1)

Publication Number Publication Date
ID24566A true ID24566A (id) 2000-07-27

Family

ID=16469018

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000167A ID24566A (id) 1997-07-29 1998-07-27 Obat untuk alopesia

Country Status (21)

Country Link
US (1) US6380179B1 (de)
EP (1) EP0998930B1 (de)
KR (1) KR20010022066A (de)
CN (1) CN1129433C (de)
AT (1) ATE262337T1 (de)
AU (1) AU733830B2 (de)
BR (1) BR9811293A (de)
CA (1) CA2298851A1 (de)
DE (1) DE69822636T2 (de)
DK (1) DK0998930T3 (de)
ES (1) ES2218840T3 (de)
HU (1) HUP0003159A3 (de)
ID (1) ID24566A (de)
IL (1) IL134199A0 (de)
NO (1) NO20000469L (de)
NZ (1) NZ502537A (de)
PL (1) PL338414A1 (de)
PT (1) PT998930E (de)
RU (1) RU2193887C2 (de)
TR (1) TR200000263T2 (de)
WO (1) WO1999006050A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2221703T3 (es) * 1997-02-26 2005-01-01 Sankyo Company Limited Compuesto azasteroide para el tratamiento o la prevencion del cancer de prostata.
JP2007518827A (ja) * 2004-02-02 2007-07-12 シェーリング コーポレイション Cd200およびcd200rを調節する方法
ES2646512T3 (es) * 2005-06-24 2017-12-14 Arizona Board Of Regents, Acting On Behalf Of The University Of Arizona Método para el tratamiento de trastornos del crecimiento del cabello, tales como la alopecia de patrón femenino, y composiciones útiles para el mismo
US20080108681A1 (en) * 2006-10-27 2008-05-08 Access Business Group International Llc Use of allantoin as a pro-collagen synthesis agent in cosmetic compositions
EP3871671A3 (de) 2009-07-29 2022-03-09 Olsen, Elise Fp rezeptorantagonisten zur hemmung von haarwachstum
MX2010012945A (es) * 2010-11-24 2012-05-24 Fidel Ojeda Gomez Una formula para el control y eliminacion de seborrea y alopecia en el cuero cabelludo.
RU2477155C2 (ru) * 2011-04-27 2013-03-10 Закрытое акционерное общество "Патент-Фарм" Способ лечения андрогенетической алопеции

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571817A (en) 1984-02-27 1996-11-05 Merck & Co., Inc. Methods of treating androgenic alopecia with finasteride [17β-N-mono-substituted-carbamoyl-4-aza-5-α-androst-1-en-ones]
US5516768A (en) 1990-03-16 1996-05-14 Smithkline Beecham Corporation Uncompetitive inhibition of steroid and 5α-reductose
IE76452B1 (en) 1990-10-29 1997-10-22 Sankyo Co Azasteroid compounds for the treatment of prostatic hypertrophy their preparation and use
JP3030152B2 (ja) * 1992-02-03 2000-04-10 三共株式会社 4−アザステロイド化合物
US5278159A (en) * 1992-10-06 1994-01-11 Merck & Co., Inc. Aryl ester derivatives of 3-oxo-4-aza-androstane 17-β-carboxylates as 5-α-reductase inhibitors
US5486511A (en) * 1993-05-25 1996-01-23 Merrell Dow Pharmaceuticals Inc. 4-amino-17β-(cyclopropyloxy)androst-4-en-3-one, 4-amino-17β-(cyclopropylamino)androst-4-en-3-one and related compounds as C17-20 lyase and 5α-reductase
TW382595B (en) 1993-10-15 2000-02-21 Merck & Co Inc Pharmaceutical composition for use in arresting and reversing androgenic alopecia
JPH0873492A (ja) * 1994-06-28 1996-03-19 Sankyo Co Ltd アザステロイド類
US5635197A (en) 1995-03-21 1997-06-03 Eli Lilly And Company Treatment and prevention of prostatic cancer metastasis
US5629007A (en) 1995-03-21 1997-05-13 Eli Lilly And Company Method of preventing prostatic cancer development
WO1997011702A1 (en) 1995-09-27 1997-04-03 Merck & Co., Inc. Method of preventing androgenetic alopecia with 5-alpha reductase inhibitors
CZ289856B6 (cs) * 1996-02-05 2002-04-17 Sankyo Company Limited Farmaceutický prostředek na bázi inhibitoru 5alfa-reduktázy
US6093722A (en) 1997-02-26 2000-07-25 Sankyo Company, Limited Method for treating prostate cancer
ES2221703T3 (es) * 1997-02-26 2005-01-01 Sankyo Company Limited Compuesto azasteroide para el tratamiento o la prevencion del cancer de prostata.

Also Published As

Publication number Publication date
DE69822636D1 (de) 2004-04-29
NO20000469L (no) 2000-03-28
HK1027290A1 (en) 2001-01-12
ES2218840T3 (es) 2004-11-16
CN1129433C (zh) 2003-12-03
IL134199A0 (en) 2001-04-30
EP0998930A1 (de) 2000-05-10
PL338414A1 (en) 2000-11-06
AU8358598A (en) 1999-02-22
DK0998930T3 (da) 2004-04-26
HUP0003159A2 (hu) 2001-04-28
EP0998930B1 (de) 2004-03-24
NO20000469D0 (no) 2000-01-28
NZ502537A (en) 2002-11-26
EP0998930A4 (de) 2002-06-12
TR200000263T2 (tr) 2000-09-21
DE69822636T2 (de) 2005-01-05
CA2298851A1 (en) 1999-02-11
KR20010022066A (ko) 2001-03-15
HUP0003159A3 (en) 2001-07-30
ATE262337T1 (de) 2004-04-15
WO1999006050A1 (en) 1999-02-11
BR9811293A (pt) 2000-08-29
CN1271285A (zh) 2000-10-25
PT998930E (pt) 2004-05-31
US6380179B1 (en) 2002-04-30
RU2193887C2 (ru) 2002-12-10
AU733830B2 (en) 2001-05-24

Similar Documents

Publication Publication Date Title
EP1206937A4 (de) Nikroimidazolpräparationen zur äusseren anwendung zur behandlung der dermatose
PT918776E (pt) Sintese total de acilfulvenos antitumorais
DK0564350T3 (da) 3, 5-di-tert-butyl-4-hydroxyflavoner, fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger med antioxidant- og anti-vasokonstriktorisk virkning
NZ313185A (en) 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives
BG104569A (en) Substituted 2-benzylamino-2-phenyl-acetamide compounds
AU681021B2 (en) Indole derivative and medicine containing the same
PL338414A1 (en) Drug against alopecia
NO981393L (no) Guanidinoproteasehemmere
MX9805023A (es) Derivados de 1-metilcarbapenem.
NO994107L (no) Preparater for behandling eller forhindring av prostatakreft
ATE196910T1 (de) 7-glykosyloxybenzopyranderivat und dieses enthaltendes antiallergisches mittel
EP0997457A4 (de) 3-benzoylindol-derivate und sie enthaltende medikamente
DE69528984D1 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten
ATE206699T1 (de) Uch-15-verbindungen
AU4544096A (en) New derivatives of glycylanilides, preparation and therapeutical application